Cargando…

Metabolic profiling distinguishes three subtypes of Alzheimer's disease

The cause of Alzheimer's disease is incompletely defined, and no truly effective therapy exists. However, multiple studies have implicated metabolic abnormalities such as insulin resistance, hormonal deficiencies, and hyperhomocysteinemia. Optimizing metabolic parameters in a comprehensive way...

Descripción completa

Detalles Bibliográficos
Autor principal:	Bredesen, Dale E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586104/ https://www.ncbi.nlm.nih.gov/pubmed/26343025

Ejemplares similares

Inhalational Alzheimer's disease: an unrecognized—and treatable—epidemic
por: Bredesen, Dale E.
Publicado: (2016)

Dynamic self-guiding analysis of Alzheimer's disease
por: Kurakin, Alexei, et al.
Publicado: (2015)

Alzheimer’s disease as a systems network disorder: chronic stress/dyshomeostasis, innate immunity, and genetics
por: Kurakin, Alexei, et al.
Publicado: (2020)

Neurodegeneration in Alzheimer's disease: caspases and synaptic element interdependence
por: Bredesen, Dale E
Publicado: (2009)

Next generation therapeutics for Alzheimer's disease
por: Bredesen, Dale E, et al.
Publicado: (2013)

Reversal of cognitive decline in Alzheimer's disease
por: Bredesen, Dale E., et al.
Publicado: (2016)

Neuroprotective Herbs for the Management of Alzheimer’s Disease
por: Gregory, Julie, et al.
Publicado: (2021)

Ayurvedic medicinal plants for Alzheimer's disease: a review
por: Rao, Rammohan V, et al.
Publicado: (2012)

Reversal of cognitive decline: A novel therapeutic program
por: Bredesen, Dale E.
Publicado: (2014)

Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer’s Disease and MCI: A Review
por: Rao, Rammohan V., et al.
Publicado: (2023)

Stratifying nonfunctional pituitary adenomas into two groups distinguished by macrophage subtypes
por: Yagnik, Garima, et al.
Publicado: (2019)

Alzheimer’s Model Develops Early ADHD Syndrome
por: Zhang, Qiang, et al.
Publicado: (2015)

Dysregulation of antimicrobial peptide expression distinguishes Alzheimer’s disease from normal aging
por: Wang, Min, et al.
Publicado: (2020)

Identification of metabolism-related subtypes and feature genes in Alzheimer’s disease
por: Lian, Piaopiao, et al.
Publicado: (2023)

Distinguishing Glioblastoma Subtypes by Methylation Signatures
por: Zhang, Yu-Hang, et al.
Publicado: (2020)

Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes
por: Saeui, Christopher T., et al.
Publicado: (2018)

Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer’s disease patients from non-demented subjects
por: Nagaraj, Siranjeevi, et al.
Publicado: (2017)

Imaging of glucose metabolism by 13C-MRI distinguishes pancreatic cancer subtypes in mice
por: Kishimoto, Shun, et al.
Publicado: (2019)

Molecular Features Distinguish Gastric Cancer Subtypes
por: De Re, Valli
Publicado: (2018)

Detection of cellular senescence within human invasive breast carcinomas distinguishes different breast tumor subtypes
por: Cotarelo, Cristina L., et al.
Publicado: (2016)

Distinguishing Frontotemporal Dementia From Alzheimer Disease Through Everyday Function Profiles: Trajectories of Change
por: Giebel, Clarissa M., et al.
Publicado: (2020)

Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer
por: Ochoa, Andrea E., et al.
Publicado: (2016)

Precision Medicine Approach to Alzheimer’s Disease: Successful Pilot Project
por: Toups, Kat, et al.
Publicado: (2022)

CSF neurogranin or tau distinguish typical and atypical Alzheimer disease
por: Wellington, Henrietta, et al.
Publicado: (2018)

mCiRNA—Synaptic Crystal Ball?
por: Bredesen, Dale
Publicado: (2012)

Molecular subtypes of Alzheimer’s disease
por: Di Fede, Giuseppe, et al.
Publicado: (2018)

A three-marker protein biosignature distinguishes tuberculosis from other respiratory diseases in Gambian children
por: Togun, Toyin, et al.
Publicado: (2020)

Metabolic reprogramming and Notch activity distinguish between non-small cell lung cancer subtypes
por: Sellers, Katherine, et al.
Publicado: (2019)

Shotgun mass spectrometry-based lipid profiling identifies and distinguishes between chronic inflammatory diseases
por: Matthiesen, Rune, et al.
Publicado: (2021)

Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
por: Spilman, Patricia, et al.
Publicado: (2010)

Metabolic profiling of Alzheimer's disease brains
por: Inoue, Koichi, et al.
Publicado: (2013)

Metabolic profiles of triple-negative and luminal A breast cancer subtypes in African-American identify key metabolic differences
por: Tayyari, Fariba, et al.
Publicado: (2018)

Metabolic profiling of the three neural derived embryonal pediatric tumors retinoblastoma, neuroblastoma and medulloblastoma, identifies distinct metabolic profiles
por: Kohe, Sarah E., et al.
Publicado: (2018)

Distinguishing Ichthyoses by Protein Profiling
por: Rice, Robert H., et al.
Publicado: (2013)

The 'Langdons'—Three Distinguished Fellows
por: Sakula, Alex
Publicado: (1985)

Diagnostic Value of Gadoxetic Acid-Enhanced MR Imaging to Distinguish HCA and Its Subtype from FNH: A Systematic Review
por: Guo, Yongfei, et al.
Publicado: (2017)

Distinguishing Lipid Subtypes by Amplifying Contrast from J-Coupling
por: Uche, Ifeanyi K., et al.
Publicado: (2019)

Longitudinal cognitive performance of Alzheimer's disease neuropathological subtypes
por: Uretsky, Madeline, et al.
Publicado: (2021)

Genomic DNA methylation distinguishes subtypes of human focal cortical dysplasia
por: Kobow, Katja, et al.
Publicado: (2019)

Mitochondrial transporter expression patterns distinguish tumor from normal tissue and identify cancer subtypes with different survival and metabolism
por: Wohlrab, Hartmut, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dm51evq1mvmcdbr3ldins7o3de